Search research articles
Contact Us
Filters
Showing results (11-20 of 86) with videos related to
Page
of 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2013
But some neoadjuvant schedules are more equal than others
David Tan, Rob Glynne-Jones
Surgical Oncology Clinics of North America
|
November 28, 2016
Treatment of the Primary Tumor in Anal Canal Cancers
Rob Glynne-Jones, Sheela Rao
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2017
We Have the Tools: It's Time to Use Them Correctly!
Marcia Hall, Rob Glynne-Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 21, 2007
Neoadjuvant cisplatin chemotherapy before chemoradiation: a flawed paradigm?
Rob Glynne-Jones, Peter Hoskin
The Lancet. Oncology
|
March 14, 2020
FOLFOXIRI reintroduction in metastatic colorectal cancer
Rob Glynne-Jones, Mark Harrison
Hematology/Oncology Clinics of North America
|
November 3, 2012
Current treatment of anal squamous cell carcinoma
Rob Glynne-Jones, Andrew Renehan
The British Journal of Surgery
|
March 2, 2024
Colorectal cancer para-aortic lymph node metastases: surgery should not be considered
Rob Glynne-Jones, Mark Harrison
Cancer Treatment Reviews
|
April 1, 2011
Chemotherapy/chemoradiation in anal cancer: a systematic review
Faye Lim, Rob Glynne-Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2017
Cetuximab in the Context of Current Treatment of Squamous Cell Carcinoma of the Anus
Rob Glynne-Jones, Mark Harrison
The Oncologist
|
December 7, 2007
Locally advanced rectal cancer: what is the evidence for induction chemoradiation?
Rob Glynne-Jones, Mark Harrison
Page
of 9
Search research articles
Search
Showing results (11-20 of 86) with videos related to
Sort By:
Page
of 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2013
But some neoadjuvant schedules are more equal than others
David Tan, Rob Glynne-Jones
Surgical Oncology Clinics of North America
|
November 28, 2016
Treatment of the Primary Tumor in Anal Canal Cancers
Rob Glynne-Jones, Sheela Rao
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2017
We Have the Tools: It's Time to Use Them Correctly!
Marcia Hall, Rob Glynne-Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 21, 2007
Neoadjuvant cisplatin chemotherapy before chemoradiation: a flawed paradigm?
Rob Glynne-Jones, Peter Hoskin
The Lancet. Oncology
|
March 14, 2020
FOLFOXIRI reintroduction in metastatic colorectal cancer
Rob Glynne-Jones, Mark Harrison
Hematology/Oncology Clinics of North America
|
November 3, 2012
Current treatment of anal squamous cell carcinoma
Rob Glynne-Jones, Andrew Renehan
The British Journal of Surgery
|
March 2, 2024
Colorectal cancer para-aortic lymph node metastases: surgery should not be considered
Rob Glynne-Jones, Mark Harrison
Cancer Treatment Reviews
|
April 1, 2011
Chemotherapy/chemoradiation in anal cancer: a systematic review
Faye Lim, Rob Glynne-Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2017
Cetuximab in the Context of Current Treatment of Squamous Cell Carcinoma of the Anus
Rob Glynne-Jones, Mark Harrison
The Oncologist
|
December 7, 2007
Locally advanced rectal cancer: what is the evidence for induction chemoradiation?
Rob Glynne-Jones, Mark Harrison
Page
of 9